CERS
Price
$1.26
Change
+$0.06 (+5.00%)
Updated
Aug 22 closing price
Capitalization
242.5M
67 days until earnings call
LAB
Price
$1.27
Change
+$0.07 (+5.83%)
Updated
Aug 22 closing price
Capitalization
485.13M
79 days until earnings call
Interact to see
Advertisement

CERS vs LAB

Header iconCERS vs LAB Comparison
Open Charts CERS vs LABBanner chart's image
Cerus
Price$1.26
Change+$0.06 (+5.00%)
Volume$1.59M
Capitalization242.5M
Standard BioTools
Price$1.27
Change+$0.07 (+5.83%)
Volume$2.07M
Capitalization485.13M
CERS vs LAB Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. LAB commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and LAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (CERS: $1.26 vs. LAB: $1.27)
Brand notoriety: CERS and LAB are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CERS: 148% vs. LAB: 100%
Market capitalization -- CERS: $242.5M vs. LAB: $485.13M
CERS [@Medical/Nursing Services] is valued at $242.5M. LAB’s [@Medical/Nursing Services] market capitalization is $485.13M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.77B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileLAB’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • LAB’s FA Score: 1 green, 4 red.
According to our system of comparison, both CERS and LAB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while LAB’s TA Score has 3 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 4 bearish.
  • LAB’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CERS is a better buy in the short-term than LAB.

Price Growth

CERS (@Medical/Nursing Services) experienced а +2.02% price change this week, while LAB (@Medical/Nursing Services) price change was +3.25% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.60%. For the same industry, the average monthly price growth was +1.52%, and the average quarterly price growth was +6.50%.

Reported Earning Dates

CERS is expected to report earnings on Oct 30, 2025.

LAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.60% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LAB($485M) has a higher market cap than CERS($242M). CERS YTD gains are higher at: -17.857 vs. LAB (-27.429). CERS has higher annual earnings (EBITDA): -8.62M vs. LAB (-120.98M). LAB has more cash in the bank: 237M vs. CERS (78M). LAB has less debt than CERS: LAB (28.6M) vs CERS (98.9M). CERS has higher revenues than LAB: CERS (193M) vs LAB (172M).
CERSLABCERS / LAB
Capitalization242M485M50%
EBITDA-8.62M-120.98M7%
Gain YTD-17.857-27.42965%
P/E RatioN/AN/A-
Revenue193M172M112%
Total Cash78M237M33%
Total Debt98.9M28.6M346%
FUNDAMENTALS RATINGS
CERS vs LAB: Fundamental Ratings
CERS
LAB
OUTLOOK RATING
1..100
6324
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LAB's Valuation (33) in the Medical Specialties industry is in the same range as CERS (36). This means that LAB’s stock grew similarly to CERS’s over the last 12 months.

LAB's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CERS (100). This means that LAB’s stock grew similarly to CERS’s over the last 12 months.

LAB's SMR Rating (96) in the Medical Specialties industry is in the same range as CERS (96). This means that LAB’s stock grew similarly to CERS’s over the last 12 months.

LAB's Price Growth Rating (59) in the Medical Specialties industry is in the same range as CERS (64). This means that LAB’s stock grew similarly to CERS’s over the last 12 months.

LAB's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as CERS (100). This means that LAB’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSLAB
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WOSGF4.550.12
+2.78%
Watches of Switzerland Group PLC
SKFOF239.004.97
+2.12%
Sika Finanz Ag
ELCO42.25N/A
N/A
Elcom International, Inc.
VLPNF21.93N/A
N/A
Voestalpine AG
BVERS3050.00N/A
N/A
Beaver Coal Co., Ltd.

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with CLPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+5.42%
CLPT - CERS
49%
Loosely correlated
+4.49%
LAB - CERS
49%
Loosely correlated
+5.83%
SGHT - CERS
47%
Loosely correlated
+2.67%
ITGR - CERS
46%
Loosely correlated
+3.51%
NNOX - CERS
46%
Loosely correlated
+1.25%
More